Latest news
Solid Biosciences (NASDAQ:SLDB) Posts Earnings Results, Beats Estimates By $0.08 EPS - MarketBeatMarketBeat · Sat, 08 Aug 2026 04:15:52 GMTSolid Biosciences files prospectus supplement for up to $200 million stock offering - Investing.com NigeriaInvesting.com Nigeria · Fri, 07 Aug 2026 07:49:25 GMTSolid Biosciences reports Q2 EPS (38c), consensus (47c) - TipRanksTipRanks · Fri, 07 Aug 2026 00:00:04 GMTSolid Biosciences (NASDAQ: SLDB) sets $200M stock sale capacity - stocktitan.netstocktitan.net · Thu, 06 Aug 2026 21:16:32 GMTSolid Biosciences Inc. Q2 2026: Revenue $0 Net loss $(54.8M), EPS $(0.38) — 10-Q Summary - TradingViewTradingView · Thu, 06 Aug 2026 20:11:01 GMTSolid Biosciences Reports Second Quarter 2026 Financial Results and Provides Business Updates - GlobeNewswireGlobeNewswire · Thu, 06 Aug 2026 20:08:47 GMTFMR LLC and Abigail Johnson (SLDB) disclose 7% beneficial stake in Solid Biosciences - stocktitan.netstocktitan.net · Thu, 06 Aug 2026 14:42:10 GMTSolid Biosciences (SLDB) Expected to Release Quarterly Earnings on Tuesday - MarketBeatMarketBeat · Tue, 04 Aug 2026 16:50:19 GMT